Some of the molecular abnormalities encountered in endometriosis‐associated ovarian cancer include: the activation of oncogenic KRAS and PI3 K pathways and the inactivation of tumor suppressor genes PTEN and AT‐Rich Interaction Domain 1A (ARID1A). The gene discussed is KRAS; the disease is endometriosis.